IKSUDA Trademark

Trademark Overview


On Thursday, May 17, 2018, a trademark application was filed for IKSUDA with the United States Patent and Trademark Office. The USPTO has given the IKSUDA trademark a serial number of 79240120. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Wednesday, October 8, 2025. This trademark is owned by IKSUDA THERAPEUTICS LIMITED. The IKSUDA trademark is filed in the Chemical Products, Pharmaceutical Products, Paper & Printed Material Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of cancer; pharmaceuticals and medical preparations for the treatment of inflammatory diseases; vaccines for the treatment of cancer; vaccines for the treatment of gene and cell therapy; vaccines for the treatment of inflammatory diseases; pharmaceutical and medical preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical products for the prevention and treatment of cancer; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of inflammatory diseases; hormones and analogues for medical purposes; biopharmaceutical and pharmaceutical gene and cell therapy products, namely, therapeutic pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders

Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; medical and pharmaceutical research services; research and development of vaccines and medicines; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; scientific research; pharmaceutical research; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; medical research services in the field of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines and gene therapy; scientific ...

Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine

[ Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for industrial use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs ]
iksuda

General Information


Serial Number79240120
Word MarkIKSUDA
Filing DateThursday, May 17, 2018
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateWednesday, October 8, 2025
Registration Number5766418
Registration DateTuesday, June 4, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements


Translation of Words in MarkThe wording "IKSUDA" has no meaning in a foreign language.
Goods and ServicesPharmaceuticals for the treatment of cancer; pharmaceuticals and medical preparations for the treatment of inflammatory diseases; vaccines for the treatment of cancer; vaccines for the treatment of gene and cell therapy; vaccines for the treatment of inflammatory diseases; pharmaceutical and medical preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical products for the prevention and treatment of cancer; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of inflammatory diseases; hormones and analogues for medical purposes; biopharmaceutical and pharmaceutical gene and cell therapy products, namely, therapeutic pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
Goods and ServicesScientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; medical and pharmaceutical research services; research and development of vaccines and medicines; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; scientific research; pharmaceutical research; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; medical research services in the field of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines and gene therapy; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; information, advisory and consultancy services relating to the aforesaid
Goods and ServicesPaper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine
Goods and Services[ Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for industrial use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, October 8, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateThursday, September 13, 2018
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 13, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIKSUDA THERAPEUTICS LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameIKSUDA THERAPEUTICS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameIKSUDA THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, September 6, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, September 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 13, 2018ASSIGNED TO EXAMINER
Monday, September 17, 2018NON-FINAL ACTION WRITTEN
Tuesday, September 18, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, September 18, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 24, 2018REFUSAL PROCESSED BY MPU
Monday, September 24, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 13, 2018REFUSAL PROCESSED BY IB
Thursday, January 31, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 1, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, February 4, 2019ASSIGNED TO LIE
Thursday, February 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 13, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 27, 2019NOTICE OF PUBLICATION
Wednesday, February 27, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 27, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 16, 2019NOTIFICATION PROCESSED BY IB
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 4, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 4, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 12, 2019FINAL DISPOSITION PROCESSED
Thursday, September 12, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 18, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 22, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 12, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, June 4, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 29, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 27, 2025TEAS SECTION 71 RECEIVED
Monday, October 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 8, 2025REGISTERED - PARTIAL SEC 71 ACCEPTED
Wednesday, October 8, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED